The STAT3 signaling pathway, crucial for tumor growth and survival, was significantly inhibited by faberidilactone A, as evidenced by reduced STAT3 phosphorylation and downregulation of downstream targets such as cyclin D1 and Mcl-1 [22,28,29]. Here, STAT3 is linked to neoplasm.